6 Retirement Costs You Might Underestimate

Retirees face substantial underappreciated costs that can materially erode retirement portfolios: Fidelity estimates a 65‑year‑old retiring in 2025 will average $172,500 in lifetime medical expenses (and $345,000 for a married couple), while Genworth reports median care costs of $77,792/year for a home health aide and $111,325/year for a nursing‑home semiprivate room. The piece highlights a >50% chance of needing long‑term services and supports (LTSS) and warns that ~3% inflation over 25 years can halve purchasing power, while also flagging ongoing housing, tax, and family support costs; it recommends factoring long‑term care insurance and inflation‑hedging assets such as dividend‑paying stocks into retirement planning.

Analysis

Market structure is bifurcating: large vertically integrated insurers and Medicare‑Advantage players (pricing power, scale to absorb wage inflation) gain relative share, while small/levered senior‑housing operators and pure‑play home‑health chains face margin compression as labor and care intensity rise. Real‑asset owners of senior housing (REITs) will be re‑rated by cap‑rate moves and occupancy trends; those with flexible payor mixes keep negotiating power.

Tail risks center on policy shifts (a federal LTC program or Medicaid reimbursement change) and an insurer reserve shock if LTC pricing proves actuarially inadequate; either could move prices and capital requirements suddenly. Immediate signals (days/weeks) are wage CPI and Fed policy comments; medium (3–12 months) is insurer earnings and rate resets; long (2–5 years) is demographic uptake and insurance‑penetration changes.

Trade implications: favor macro hedges to inflation in duration (TIPS) and high‑quality, dividend‑paying healthcare/consumer staples to defend cash flows, while selectively short levered operators with weak balance sheets. Use options to express convexity: buy multi‑month call spreads on insurers and buy puts on fragile operators to limit downside and cost of carry.

Contrarian view: the market understates structural pricing power of MA insurers and overestimates near‑term capex need for well‑capitalized REITs; conversely, LTC insurance issuance could surprise to the upside if insurers reprice aggressively, creating a short‑term supply shock of higher premiums that re‑allocates demand to private pay and annuities. Historical parallels to pharmaceutical pricing resets suggest rapid repricing is possible within 12–18 months.

Key Decisions for Investors

• Establish a 2–3% long position in UnitedHealth (UNH) and Humana (HUM) combined (equal‑weight) within 30 days; add on any 5% pullback; target 12–24 month horizon to capture MA pricing power and reserve repricing.
• Allocate 3–5% to TIPS exposure (e.g., ITIP or TIP ETF) within 2 weeks if 10‑yr real yield <0.5% or CPI prints >3% y/y; hold as inflation/LTC‑cost hedge for 1–3 years.
• Initiate a 1–2% short position in Encompass Health (EHC) or Amedisys (AMED) within 60 days, size with a 12% stop‑loss; rationale: margin squeeze from wages and high private‑pay sensitivity, horizon 3–9 months.
• Buy 9–12 month call spreads on UNH (debit spread sized to 0.5–1% notional) to play asymmetric upside from better‑than‑expected margin recovery while capping premium outlay; roll or take profits at +50%.
• Rotate 3–5% into high‑quality dividend strategy (NOBL or select names JNJ, PG) and sell 30–60 day covered calls to generate 3–6% annualized incremental yield; close or unwind if dividend yield falls below 2.5% or if CPI drops below 1.5% y/y.